HRSA will award up to $1 million to a single organization to update the Women's Preventive Services Guidelines through the new WISH program.
Soma Mandal, MD, MSCP, says removing MHT boxed warnings is overdue but calls for transparency on the FDA's product-specific ...
CMS' proposed G-codes, which experts stated would cause confusion in combination with the AMA's proposed codes, were not ...
Swanson, PhD, on a pilot in which integrative group medical visits improved menopause symptoms, knowledge, and self-efficacy.
The FDA granted accelerated approval to Voceryq to reduce papilloma excision surgeries in adults with recurrent respiratory papillomatosis.
A recap of the top women's health headlines from October 2026, including FDA approval of pritelivir for refractory HSV, ACOG's new menopause guideline, and more.
Susan Reed, MD, MPH, MS, and Calbeth C. Alaribe, DMSc, MPH, PA-C, CPCHE, weigh in on FDA boxed warning removals for menopausal hormone therapy.
Pauline M. Maki, PhD, explains that clinicians caring for midlife women now have a range of solutions for vasomotor symptoms (VMS). Pauline M. Maki, PhD, explains that clinicians caring for midlife ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results